Related Experiment Video

Updated: Jun 5, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Update on the biology and clinical study of restenosis

E R O'Brien1, S M Schwartz

  • 1University of Ottawa Heart Institute, Division of Cardiology, Ottawa, Ontario K1Y 4E9, Canada.

Trends in Cardiovascular Medicine
|January 20, 2011
PubMed

Insights

Restenosis after coronary procedures may not stem from uncontrolled cell growth. New findings question the traditional view, suggesting other factors drive this common vascular complication.

Area of Science:

  • Cardiovascular Biology
  • Vascular Medicine
  • Pathophysiology

Background:

  • Restenosis is a common complication following coronary interventional procedures.
  • It is traditionally attributed to uncontrolled cellular proliferation within the vessel wall.

Purpose of the Study:

  • To question the established understanding of restenosis pathophysiology.
  • To explore alternate biological and clinical processes contributing to restenosis.

Main Methods:

  • Review of clinical studies on lumen renarrowing.
  • Analysis of coronary atherectomy specimens for cell proliferation.
  • Evaluation of diagnostic limitations of arteriography.

Main Results:

  • Cell proliferation in restenotic coronary atherectomy specimens was found to be modest and infrequent.
  • Arteriography provides limited information on vessel wall mass changes, impacting restenosis assessment.

Conclusions:

  • Existing concepts of restenosis pathophysiology, primarily focused on cellular proliferation, may be incomplete.
  • Alternate biological and clinical factors warrant further investigation to understand and manage restenosis effectively.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...